Fluoroalkene modification of mercaptoacetamide-based histone deacetylase inhibitors

Bioorganic & Medicinal Chemistry
2010.0

Abstract

Inhibitors of histone deacetylases (HDAC) are emerging as a promising class of anti-cancer agents. The mercaptoacetoamide-based inhibitors are reported to be less toxic than hydroxamate and are worthy of further consideration. Therefore, we have designed a series of analogs as potential inhibitors of HDACs, in which the mercaptoacetamide group was replaced by (mercaptomethyl)fluoroalkene, and their HDAC inhibitory activity was evaluated. Subnanomolar inhibition was observed for all synthetic compounds.

Knowledge Graph

Similar Paper

Fluoroalkene modification of mercaptoacetamide-based histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry 2010.0
Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2005.0
Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor
ACS Medicinal Chemistry Letters 2018.0
Novel amide derivatives as inhibitors of histone deacetylase: Design, synthesis and SAR
European Journal of Medicinal Chemistry 2009.0
α-Mercaptoketone based histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthesis and biochemical analysis of 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoro-N-hydroxy-octanediamides as inhibitors of human histone deacetylases
Bioorganic & Medicinal Chemistry 2012.0
Thiol-based SAHA analogues as potent histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design
Bioorganic & Medicinal Chemistry Letters 2005.0
Design, synthesis and biological evaluation of novel histone deacetylase inhibitors incorporating 4-aminoquinazolinyl systems as capping groups
Bioorganic & Medicinal Chemistry Letters 2017.0
Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors
Bioorganic & Medicinal Chemistry 2015.0